Yılmaz, N. K. (2026). Dasatinib as a Repurposing Candidate for Alzheimer’s Disease: An Integrated In Silico Network Pharmacology and Molecular Docking Study. Trends in Pharmacy, 3, 1–11. https://doi.org/10.5152/TIP.2026.26015